Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.
about
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cellsCXCR5⁺ T helper cells mediate protective immunity against tuberculosisThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunityDoes IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the DiseaseTh17 plasticity and its changes associated with inflammatory bowel diseaseThe involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensisT cell-mediated host immune defenses in the lungMacrophages participate in IL-17-mediated inflammationNKT cell stimulation with α-galactosylceramide results in a block of Th17 differentiation after intranasal immunization in miceIntranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challengeCD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.Differential Cultivation of Francisella tularensis Induces Changes in the Immune Response to and Protective Efficacy of Whole Cell-Based Inactivated VaccinesProfiling early lung immune responses in the mouse model of tuberculosis.Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.Induction and activation of human Th17 by targeting antigens to dendritic cells via dectin-1.Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense.An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infectionTh17 cytokines in mucosal immunity and inflammation.Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections.The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection.Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cellsResolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cellsThe role of Th17 cytokines in primary mucosal immunityA Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacySM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.IL-17 in protective immunity to intracellular pathogens.Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemiaHost-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicityIL-23 p19 knockout mice exhibit minimal defects in responses to primary and secondary infection with Francisella tularensis LVSTc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells.MyD88 deficiency leads to decreased NK cell gamma interferon production and T cell recruitment during Chlamydia muridarum genital tract infection, but a predominant Th1 response and enhanced monocytic inflammation are associated with infection resolA mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signalingIL-17 and Th17 cells in tuberculosis
P2860
Q24626339-F99E1F0B-0ACC-4107-83A0-1AF722D76B47Q24628780-B8947169-B2AE-4F6C-847F-AE337087865DQ26750673-4083E0DD-B79C-42CA-806C-E8A67025BD96Q26768646-D93A0054-6B91-41F1-9193-C198FFCA4A8BQ26771264-3E21D22C-6810-41FE-BB8E-F5821AE922E2Q26775934-35C7540D-94A3-4214-A28B-93BFB8DDD37DQ27324829-2A65965B-D27B-4016-9C22-4E0AC7C51BA7Q28395374-6F7EF473-0D94-4D74-9918-32536E93B27CQ28652293-09D79ABD-CFE0-4CC9-A86E-C22B215AD87EQ28732417-2E380439-0832-46AF-BF65-E455CB6AB418Q28743895-CE39108D-9139-4A94-8882-ECC56A8D04A6Q30428781-562F25C8-2D7D-4B8E-B1C2-0765A34AF985Q30834372-AE4AAE78-CF1A-426C-A5CB-B669BCFA8394Q30996626-D32BD46E-288A-4D68-8FE9-6A27171A1836Q33619034-3FB840D0-D624-4842-A7CD-EA37C4F7C7AEQ33723950-0373AE74-4172-4A07-84D7-B6FE18048836Q33725674-14CFAD40-5F4A-4DEA-B8EF-4DCDAC0615BBQ33730117-FEDE2604-6578-4BB1-834C-37DC1854608CQ33788735-A0D9B012-BD96-4E5B-A06D-1C02D5E6F2C8Q33802696-082D7BD6-E1FE-47A6-B5BE-69CFEB81C483Q33822265-234E2726-AE08-4FCA-9471-B3E9F120AD9DQ33943805-76C98408-3BBB-4817-8186-657DE38CDCD5Q33963886-447E8C1B-76FC-47CE-9B42-0B87A935F747Q33987288-3A315787-3A10-41EC-A217-87E8F439CA49Q34037657-A0917487-2E50-48F5-8DBD-3B489BB10756Q34087802-F060C297-25E3-4341-8008-04AC03579353Q34118502-6AA8549F-046E-4C30-B054-8E8C0BFC6675Q34151076-158E50A6-21B3-45EF-813E-902130B4E70DQ34166276-1CEF8327-00EC-4929-8870-634941342F2DQ34184574-88FA973B-70E2-4445-B17F-C0774B950BC4Q34193357-DE075EC8-C95F-43EC-AD1D-CCE2077113C6Q34200786-3F3280F5-0EE4-464F-9486-EB3BC323D7A9Q34237666-29669B66-A6C9-457F-BD8E-2D87872541F1Q34309279-5360EEA4-500E-4A21-B449-02668B4ED5CBQ34350869-B364C3E4-5124-4664-A395-092D07754682Q34484704-8EDC029E-905B-4CB2-BEEC-F1A12735A5BDQ34500312-D47E5B4E-A33A-4A86-8D62-695380E72E00Q34519904-F22FB688-367A-47A5-BFD1-4F6E4F3EF949Q34534351-22BD17B1-F49E-4D3D-8CD6-5E20769FF4E4Q34545889-49082E3F-74BF-43C5-B33F-FA8F1B1EDD10
P2860
Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Interleukin-17 is required for ...... thogen Francisella tularensis.
@ast
Interleukin-17 is required for ...... thogen Francisella tularensis.
@en
type
label
Interleukin-17 is required for ...... thogen Francisella tularensis.
@ast
Interleukin-17 is required for ...... thogen Francisella tularensis.
@en
prefLabel
Interleukin-17 is required for ...... thogen Francisella tularensis.
@ast
Interleukin-17 is required for ...... thogen Francisella tularensis.
@en
P2093
P2860
P50
P1433
P1476
Interleukin-17 is required for ...... thogen Francisella tularensis.
@en
P2093
Alison Logar
Derek Pociask
Heather Strawbridge
Jay K Kolls
John F Alcorn
Michael J Walter
Nikki Nyugen
Reiko Onishi
Samantha Slight
Sang Mi Park
P2860
P304
P356
10.1016/J.IMMUNI.2009.08.025
P407
P577
2009-10-22T00:00:00Z